These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25906216)

  • 21. Testosterone deficiency as a risk factor for cardiovascular disease.
    Ullah MI; Washington T; Kazi M; Tamanna S; Koch CA
    Horm Metab Res; 2011 Mar; 43(3):153-64. PubMed ID: 21283952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone deficiency: myth, facts, and controversy.
    Miner M; Barkin J; Rosenberg MT
    Can J Urol; 2014 Jun; 21 Suppl 2():39-54. PubMed ID: 24978631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone supplementation and cardiovascular risk.
    Corona G; Maggi M
    Trends Cardiovasc Med; 2015 Apr; 25(3):258-60. PubMed ID: 25498949
    [No Abstract]   [Full Text] [Related]  

  • 24. Testosterone replacement.
    Tariman JD
    Adv Nurse Pract; 2007 May; 15(5):22. PubMed ID: 20000206
    [No Abstract]   [Full Text] [Related]  

  • 25. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
    Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
    Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In brief: testosterone and cardiovascular risk.
    Med Lett Drugs Ther; 2014 Mar; 56(1437):17. PubMed ID: 24589496
    [No Abstract]   [Full Text] [Related]  

  • 27. Testosterone therapy and cardiovascular risk: advances and controversies.
    Morgentaler A; Miner MM; Caliber M; Guay AT; Khera M; Traish AM
    Mayo Clin Proc; 2015 Feb; 90(2):224-51. PubMed ID: 25636998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone therapy and prostate cancer--safety concerns are well founded.
    Klotz L
    Nat Rev Urol; 2015 Jan; 12(1):48-54. PubMed ID: 25563848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone supplementation.
    Simonson W
    Geriatr Nurs; 2015; 36(4):312-3. PubMed ID: 26253039
    [No Abstract]   [Full Text] [Related]  

  • 30. Testosterone therapy: has overuse undermined use?
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):157. PubMed ID: 29475492
    [No Abstract]   [Full Text] [Related]  

  • 31. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk.
    Miner M; Morgentaler A; Khera M; Traish AM
    Clin Endocrinol (Oxf); 2018 Jul; 89(1):3-10. PubMed ID: 29486065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The TRAVERSE trial: cardiovascular safety of testosterone therapy for older men.
    Anawalt BD
    Lancet Diabetes Endocrinol; 2023 Oct; 11(10):714-716. PubMed ID: 37660720
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of Testosterone and Cardiovascular Risk.
    Seftel AD
    J Urol; 2016 Feb; 195(2):442. PubMed ID: 26853010
    [No Abstract]   [Full Text] [Related]  

  • 34. Testosterone deficiency and replacement in older men.
    Bremner WJ
    N Engl J Med; 2010 Jul; 363(2):189-91. PubMed ID: 20647215
    [No Abstract]   [Full Text] [Related]  

  • 35. Testosterone replacement therapy and cardiovascular risk factors modification.
    Chahla EJ; Hayek ME; Morley JE
    Aging Male; 2011 Jun; 14(2):83-90. PubMed ID: 21539436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone and cardiovascular disease.
    Schooling CM
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):202-8. PubMed ID: 24722171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extraprostatic complications of testosterone replacement therapy.
    Volpi R; Coiro V; Chiodera P; Saccani-Jotti G; Delsignore R
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):75-7. PubMed ID: 16760630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone and Cardiovascular Health.
    Elagizi A; Köhler TS; Lavie CJ
    Mayo Clin Proc; 2018 Jan; 93(1):83-100. PubMed ID: 29275030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone and cardiovascular disease--the controversy and the facts.
    Morgentaler A; Feibus A; Baum N
    Postgrad Med; 2015 Mar; 127(2):159-65. PubMed ID: 25708023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of testosterone use in women.
    Shufelt CL; Braunstein GD
    Maturitas; 2009 May; 63(1):63-6. PubMed ID: 19250779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.